LanguaTalk

Surfing the MASH Tsunami

Driving the Discussion in Fatty Liver Disease. Join hepatology researcher and Key Opinion Leader Jörn Schattenberg, Liver Wellness Advocate Louise Campbell, and Forecasting and Pricing Guru Roger Green and a global group of Key Opinion Leaders and patient advocates as they discuss key issues in Fatty Liver disease, including epidemiology, drug development, clinical pathways, non-invasive testing, health economics and regulatory issues, from their own unique perspectives on the Surfing the MASH Tsunami podcast. #MASH #MAFLD #FattyLiver #livertwitter #AASLD #GlobalLiver #NoNASH #EASL

S5 - E17.6 - From The Vault: Looking Back At The EASL Congress 2023 Preview & Program Design

17 mins; June 02, 2024

S5 - E17.5 - Previewing EASL Congress 2024: Focusing On MASLD Drug Development

12 mins; June 02, 2024

S5 - E17.4 - Previewing EASL Congress 2024: Is Big Data The Future Of MASLD?

12 mins; June 02, 2024

S5 - E17.3 - Previewing EASL Congress 2024: Jörn Schattenberg Joins The MASLD Conversation

13 mins; June 01, 2024

S5 - E17.2 - Previewing EASL Congress 2024: Collegiality, Consortia & High-Quality MASLD Abstracts

12 mins; June 01, 2024

S5 - E17.1 - Previewing EASL Congress 2024: Secretary General Aleksander Krag Shares His Vision For The Congress

13 mins; June 01, 2024

S5 - E17 - Previewing EASL Congress 2024 and its Major MASLD Moments

59 mins; May 30, 2024

S5 - E16.5 - From The Vault: Stephen Harrison Discusses FASCINATE-2 Results For Denifenstat

11 mins; May 26, 2024

S5 - E16.4 - Remembering MASLD Master Stephen Harrison: Stephen As Role Model

15 mins; May 26, 2024

S5 - E16.3 - Remembering MASLD Master Stephen Harrison: Stephen As Innovator

11 mins; May 25, 2024

S5 - E16.2 - Remembering MASLD Master Stephen Harrison: Stephen As Patient Advocate

9 mins; May 25, 2024

S5 - E16.1 - Remembering MASLD Master Stephen Harrison: Stephen As Integrator

10 mins; May 25, 2024

S5 - E16 - Remembering Stephen Harrison 2: More Memories of a MASLD Master

48 mins; May 23, 2024

S5-15.6 - From the Vault: Discussing NAIL-NIT Findings at INCBCN 2023

11 mins; May 19, 2024

S5 - E15.5 - From SLD Think-Tank 2024 Wrap-Pp: Shall We Focus More on Preventive Hepatology?

14 mins; May 19, 2024

S5 - E15.4 - From SLD Think-Tank 2024: Improving Preparedness And The Value of Having Rezdiffra

13 mins; May 19, 2024

S5 - E15.3 - From SLD Think-Tank 2024: Meeting Agenda And The "Magic Wand"

9 mins; May 18, 2024

S5 - E15.2 - From SLD Think-Tank 2024: An Innovative Stimulating Meeting Design

12 mins; May 18, 2024

S5 - E15.1 - From SLD Think-Tank 2024: Meet Maja Thiele And Learn About LiverAIM

11 mins; May 18, 2024

S5 - E15 - Highlights from SLD Think-Tank 2024, a Public Health Approach to MASH

60 hours 43 mins; May 16, 2024

S5 - E14.4 - From the Vault: Our Last Year-End Interview With MASH Master Stephen Harrison

28 mins; May 12, 2024

S5 E14.2 - Remembering Stephen Harrison: Professional Accomplishments

8 mins; May 12, 2024

S5 E14.1 - Remembering Stephen Harrison: Personal Memories

15 mins; May 12, 2024

S5 - E14.3 - Remembering Stephen Harrison: "Harrisonisms"

10 mins; May 11, 2024

S5 - E14 - Remembering Stephen Harrison - colleagues share memories and impressions of an SLD master

37 mins; May 08, 2024

S5 - E13.6 - One Year Ago: When Global Fatty Liver Day Was #NASHDay 2023

12 mins; May 05, 2024

S5 - E13.5 - MASH And The Elephant Metaphor: Attacking A Multi-Faceted, Complex Disease

13 mins; May 05, 2024

S5 - E13.4 - A Deeper Dive into Care Challenges and Barriers Affecting MASH Patient Care

14 mins; May 05, 2024

S5 - E13.3 - Practical Challenges In Patient Care: Role Of GLP-1s And Scanning

12 mins; May 04, 2024

S5 - E13.2 - Global Fatty Liver Day 2024 And The Rationale Behind "Act Now. Get Screened."

12 mins; May 04, 2024

S5 - E13.1 - Remembering SurfingMASH Co-Founder Stephen Harrison

10 mins; May 04, 2024

S5 - E13 - Previewing Global Fatty Liver Day 2024

62 hours 19 mins; May 01, 2024

S5 - E12.6 - From The Vault: More Different Roles For NITs In MASH

12 mins; April 28, 2024

S5 - E12.5 - MASH Drug Development: Combining With Old Drugs And Shortening Time To Approval

11 mins; April 28, 2024

S5 - E12.4 - MASH Drug Development: Implications Of Concomitant Metabolic Therapy Use

13 mins; April 28, 2024

S5 - E15.3 - MASH Drug Development: Improvement Since 2020 And Issues That Remain

11 mins; April 27, 2024

S5 - E12.2 - MASH Drug Development: Improving Efficacy Endpoints

12 mins; April 27, 2024

S5 - E12.1 - MASH Drug Development: The State Of The Graveyard 2023

11 mins; April 27, 2024

S5 - E12 - MASH Drug Development: What Failures Taught Us About Success

54 mins; April 25, 2024

S5 - E11.6 - From The Vault: Another Strategic Role For Prescribing MASH Drugs

11 mins; April 21, 2024

S5 - E11.5 - MASH Prescribing Models & The Increasing Challenge Of Keeping Patients In Long-Term Clinical Trials

10 mins; April 21, 2024

S5 - E11.4 - More Hot MASLD Topics: Inflammation, MD columnists' Advice, FGF-21s

10 mins; April 21, 2024

S5 - E11.3 - Panelists' Hot Topics: Low-Dose Aspirin, SLD Think Tank, Dietary Inflammation Index

13 mins; April 20, 2024

S5 - E11.2 - Defining Therapeutic Futility For Rezdiffra And Discussing Advances In MASLD Translational Medicine

11 mins; April 20, 2024

S5 - E11.1 - How The Rezdiffra Approval Has Affected How One Clinic Manages MASH Patients

11 mins; April 20, 2024

S5 - E11 - Life With Rezdiffra: Early Impact On MASH Patient Treatment and MASLD Clinical Trials

53 mins; April 17, 2024

S5 - E10 - Lessons And Insights On Using Basic EHR Data To Screen For Target MASLD Patients

56 mins; April 15, 2024

S5 - E9.6 - From The Vault: An Earlier Look At Screening In The Clinical Care Pathway

12 mins; April 07, 2024

S5 - E9.5 - In-Office Screening Post-Rezdiffra: The Importance Of Predictive Biomarkers

14 mins; April 07, 2024

S5 - E9.4 - In-office MASLD Screening and the Clinical Care Pathway

11 mins; April 07, 2024

S5 - E9.3 - How Will Increased Access To In-Office Scanning Improve MASLD Therapy:

11 mins; April 06, 2024

S5 - E9.2 - VCTE Studies Demonstrate That Multiple Nutrition Interventions Can Support MASLD Patients

10 mins; April 06, 2024

S5 - E9.1 - VCTE As A Prognostic And Therapeutic Tool For MASLD

9 mins; April 06, 2024

S5 - E9 - Value of VCTE Or Other In-Office MASLD Monitoring

53 mins; April 04, 2024

S5 - E8 - Changing Patient Incentives For Participating In MASH Clinical Trials

15 mins; April 01, 2024

S5 - E7.6 - MASLD Patient Advocates' Recommendations for Others after Rezdiffra Approval

9 mins; March 24, 2024

S5 - E7.5 - Will Increasing the Focus on MASH via Rezdiffra Overwhelm the Healthcare System?

11 mins; March 24, 2024

S5 - E7.4 - How MASH patient advocates plan to support Rezdiffra

11 mins; March 24, 2024

S5 - E7.3 - Patient advocacy and the Rezdiffra label

10 mins; March 23, 2024

S5 - E7.1 - Rezdiffra is approved! How patient and their advocates processed the news about the first MASH drug

13 mins; March 23, 2024

S5 - E7.2 - Identifying the target MASH patients for Rezdiffra

9 mins; March 22, 2024

S5 - E7 - MASLD Patient Advocates Celebrate Rezdiffra and Discuss the Future

65 hours 56 mins; March 20, 2024

S5 - E6.6 - Closing Question From The Episode On Rezdiffra, The First MASH Drug

8 mins; March 19, 2024

S5 - E6.5 - BioPharma Industry Takeaways ForBioPharma Industry Takeaways From The Rezdiffra Launch The Rezdiffra Launch

7 mins; March 19, 2024

S5 - E6.4 - Finding The MASH Patients That Are The Initial Rezdiffra Targets

12 mins; March 19, 2024

S5 - E6.3 - Staging and screening patients for Rezdiffra using NITs

15 mins; March 18, 2024

S5 - E6.2 - How Approval Of Rezdiffra,The First MASH Drug, Might Improve Patient Adherence To Lifestyle Recommendations

11 mins; March 18, 2024

S5 - E6.1 - Rezdiffra Is Approved! How Key Opinion Leaders Processed The News About The First MASH Drug

11 mins; March 18, 2024

S5 - E6 - Rezdiffra Is Here! Key Opinion Leaders React To The First MASH Drug Approval

64 hours 43 mins; March 16, 2024

S5 - E5.6 - From The Vault: Tsunami's First Look At MASEF, A Major New NIT

13 mins; March 10, 2024

S5 - E5.5 - More on GLP-1s and a Broader MASH Wrap-up

11 mins; March 10, 2024

S5 - E5.4 - The dance of drug pricing and patient targets in MASH, PLUS: the role of GLP-1s

11 mins; March 10, 2024

S5 - E5.3 - Strategies to Improve NIT reliability in Diagnosing and Staging MASH Fibrosis

14 mins; March 10, 2024

S5 - E5.2 - NITs In The Diagnosis and Treatment Of Advanced MASH Fibrosis Patients

12 mins; March 10, 2024

S5 - E5.1 - Why We Are Focusing On NITs For MASH Diagnosis And Screening

8 mins; March 09, 2024

S5 - E5 - How Non-Invasive Tests (NITs) For MASLD And MASH Might Evolve In 2024

57 mins; March 06, 2024

S5 - E4.6 - From The Vault: What a NASH Disease Model Reveals About Treating Advanced Fibrosis

15 mins; March 03, 2024

S5 - E4.5 - MASH Education As A Tool To Stem The MASLD Pandemic

9 mins; March 03, 2024

S5 - E 4.4 - Learning about the Global NASH Council's work in MASLD

8 mins; March 03, 2024

S5 - E4.1 - Appreciating The Disease Burden Of MASLD

11 mins; March 02, 2024

S5 - E4.2 - The Breadth Of MASLD Disease Burden And Cost Effectiveness Of Therapies

10 mins; March 02, 2024

S5 - E4.3 - Slowing The Growth Of The MASLD Pandemic

10 mins; March 02, 2024

S5 - E4 - MASLD Epidemiology Takes: Rapidly Proliferating Prevalence; Many Public Health Needs

52 mins; February 29, 2024

S5 - E3.6 - From the Vault: EASL Congress 2023: Focus On The New MASLD Nomenclature

15 mins; February 27, 2024

S5 - E3.5 - The New MASLD Nomenclature: What Lies Ahead For MASH Patients And Providers?

12 mins; February 27, 2024

S5 - E3.4 - Discussing MASLD With Patients: MASH Is Not "Just A Little Fat" Any More

10 mins; February 27, 2024

S5 - E3.3 - The New MASLD Nomenclature -- MASLD Rollout And Stakeholder Roles

11 mins; February 26, 2024

S5 - E3.2 - How Did The Delphi Process Work For The New MASLD Nomenclature?

13 mins; February 26, 2024

S5 - E3.1 - Why create a new MASLD nomenclature?

10 mins; February 26, 2024

S5 - E3 - The New MASLD Nomenclature And How We Got Here

59 mins; February 24, 2024

S5 - E2.5 - Conversations From The Vault: Jeff McIntyre On ICER Reviews And NITs

14 mins; February 18, 2024

S5 - E2.4 - MASLD Patient Advocates' Priority 2024 MASH Programs

15 mins; February 18, 2024

S5 - E2.3 - Where Do MASLD Patients And Advocates Fit In MASH Drug Access Decisions?

13 mins; February 17, 2024

S5 - E2.2 - After The First MASH Drug Approval, Focus Shifts To Patient Access

14 mins; February 17, 2024

S5 - E2.1 - Expectations For The Resmetirom PDUFA Date - The First MASH Drug Approval?

13 mins; February 17, 2024

S5 - E02 - MASLD Patient Advocates Plan MASH Activities For 2024

66 hours 15 mins; February 15, 2024

S5 - E1.6 - SurfingMASH Is Back! How Can Consumer Behavior Confound MASH Care?

7 mins; February 11, 2024

S5 -E1.5 - SurfingMASH Is Back! How Will GLP-1 Ads From Telemedicine Affect MASH?

8 mins; February 11, 2024

S5 - E1.4 - SurfingMASH Is Back! Reframing "Liver Awareness" In The Context Of US DTC Advertising

9 mins; February 11, 2024

S5 - E1.3 - SurfingMASH Is Back! 2024 Podcast Updates And The Increasing Need For "Liver Awareness"

8 mins; February 10, 2024

Click here to see more

Surfing the MASH Tsunami

Useful pages

Find a tutor

Languages